During the past decade, Kaiser Permanente Cancer Treatment Center conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 23 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 16 clinical trials were completed. i.e. 76.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 31 trials, followed by "NRG Oncology" with 17 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "Alliance for Clinical Trials in Oncology" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Cancer Treatment Center" are "Stage II Breast Cancer" (5 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Prostate Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials) and "Gliosarcoma" (3 trials). Many other conditions were trialed in "Kaiser Permanente Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Cancer Treatment Center" are "Drug" (56 trials), "Other" (43 trials), "Radiation" (34 trials), "Biological" (27 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (19 trials), "Questionnaire Administration" (14 trials), "Cisplatin" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Cancer Treatment Center" are 59 trials for "All" genders, 11 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Cancer Treatment Center". undefined are not yet recruiting, 23 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kaiser Permanente Cancer Treatment Center, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Cancer Treatment Center, 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".